search
Back to results

Preperitoneal Analgesia Versus Epidural Analgesia After Open Pancreaticoduodenectomy (Pain)

Primary Purpose

Pain Management, Pain, Postoperative

Status
Recruiting
Phase
Not Applicable
Locations
Korea, Republic of
Study Type
Interventional
Intervention
Epidural patient controlled analgesia
Preperitoneal analgesia and IV-PCA
Sponsored by
Seoul National University Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Pain Management focused on measuring Pain management, Postoperative pain

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • 18 years and older
  • Disease of periampullary lesions
  • Elective open pancreaticoduodenectomy (PD): PD or pylorus preserving pancreaticoduodenectomy (PPPD)
  • Midline incision
  • Written informed consent : ability to understand and the willingness to sign a written informed consent
  • Performance status (ECOG scale): 0-1 at the time of enrollment
  • Physical status (ASA) : 1-2 grade

Exclusion Criteria:

  • History of neoadjuvant chemotherapy
  • History of any abdominal surgery (except laparoscopic appendectomy, laparoscopic/robotic cholecystectomy, laparoscopic/robotic obstetrics and gynecology surgeries,Cesarean section, laparoscopic/robotic prostate surgery)
  • Emergency operation
  • History of chronic pain
  • Chronic use of opioid, analgesics, anti-depressant, anti-epileptics (>1year)
  • Alcoholics
  • Impossible to control PCA d/t delirium, cognitive impairment
  • Contraindication for epidural analgesia
  • Patients with coagulopathy (INR>1.5, Prothrombin time>1.5, platelets <80x10^9perL) or anti-coagulants
  • Hypersensitive to fentanyl and ropivacaine
  • Need other organ resection (ex. Liver, colon)
  • Intubation

Sites / Locations

  • Department of Surgery, Seoul National University College of MedicineRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Epidural analgesia

Preperitoneal analgesia and IV-PCA

Arm Description

Only Epidural analgesia is used for this group

This group is given with both preperitoneal analgesia and Intravenous Patient Controlled Analgesia (IV-PCA)

Outcomes

Primary Outcome Measures

Numerical rating score for pain at 24 hours after operation
The scale of the numerical rating score for pain is 0~10 and higher score is worse outcome. At 24 hours after operation, NRS pain scores are compared between two groups.

Secondary Outcome Measures

Pain related factors
The scale of the numerical rating score for pain is 0~10 and higher score is worse outcome. Numerical rating score for pain on postoperative day 2 and 3 at 4pm
Overall benefit of analgesia score (OBAS)
OBAS on postoperative day 1,2,and 3. This include 7 questions. To calculate the OBAS score, compute the sume of scores in items 1~6 and add "4-socore in item 7". The minimum score is 4 and the maximum is 24.The low score indicates high benefit.
Recovery related factors
Time to first eat meal, time to first move, time to first gas out
Postoperative complication factors
Clavien-Dindo classification, postoperative pancreatic fistula
analgesic related factors
rescue analgesics amounts, opioid amounts

Full Information

First Posted
April 26, 2020
Last Updated
April 10, 2023
Sponsor
Seoul National University Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT04375826
Brief Title
Preperitoneal Analgesia Versus Epidural Analgesia After Open Pancreaticoduodenectomy
Acronym
Pain
Official Title
Continuous Preperitoneal Analgesia Versus Thoracic Epidural Analgesia After Open Pancreaticoduodenectomy: A Randomized Controlled Open-labeled Noninferiority Trial
Study Type
Interventional

2. Study Status

Record Verification Date
April 2023
Overall Recruitment Status
Recruiting
Study Start Date
November 13, 2020 (Actual)
Primary Completion Date
December 31, 2023 (Anticipated)
Study Completion Date
December 31, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Seoul National University Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This is a prospective randomized open-label noninferiority trial that compares thoracic epidural analgesia and continuous preperitoneal analgesia after open pancreaticoduodenectomy.
Detailed Description
In the Enhanced recovery after surgery (ERAS) program of pancreaticoduodenectomy (PD), thoracic epidural analgesia (or epidural analgesia) was considered to be a key analgesic method because it not only effectively controls pain, but also lowers insulin resistance and helps restore bowel movement. However, epidural analgesia can cause a number of side effects despite of effective pain control. Epidural analgesia reduces peripheral vascular resistance by blocking sympathetic nerves with local anesthetics and may cause hypotension and decreasing heart rate. In addition, it can cause orthostatic hypotension, which can interfere with early ambulation after operation. In rare cases, there are potential complications of epidural abscess, meningitis, and epidural hematoma. Continuous peritoneal analgesia using local anesthetics has recently been used as an alternative analgesic to epidural analgesia in open abdomen surgery. This is easier to perform than epidural analgesia and is known to have fewer side effects. Recently, a non-inferiority comparison study have revealed that peritoneal analgesic was not inferior to epidural analgesia in terms of pain control. However, this study included a variety of operations other than PD, and most of the incisions were substernal, not midline. In addition, the method for mounting the epidural catheter was not described. The failure rate of the epidural catheter was reported to be 15%. The investigators will examine the effect of continuous peritoneal analgesic postoperative pain control in patients undergoing open PD to improve postoperative pain management and to create an our own ERAS program. To this end, The investigators will test non-inferiority between epidural analgesia and peritoneal analgesia.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pain Management, Pain, Postoperative
Keywords
Pain management, Postoperative pain

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
140 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Epidural analgesia
Arm Type
Active Comparator
Arm Description
Only Epidural analgesia is used for this group
Arm Title
Preperitoneal analgesia and IV-PCA
Arm Type
Active Comparator
Arm Description
This group is given with both preperitoneal analgesia and Intravenous Patient Controlled Analgesia (IV-PCA)
Intervention Type
Device
Intervention Name(s)
Epidural patient controlled analgesia
Intervention Description
The device is connected to the epidural catheter prior to surgery and drug administration is started during surgery. The continuous infusion rate is 4 ml / hr. When the button is pressed, 2 ml is additionally administered and the lock time is 20 minutes.
Intervention Type
Device
Intervention Name(s)
Preperitoneal analgesia and IV-PCA
Intervention Description
During surgery, the preperitoneal analgesia catheters are inserted into the preperitoneal space and these catheters are connected to the pump with ropivacaine.
Primary Outcome Measure Information:
Title
Numerical rating score for pain at 24 hours after operation
Description
The scale of the numerical rating score for pain is 0~10 and higher score is worse outcome. At 24 hours after operation, NRS pain scores are compared between two groups.
Time Frame
24 hours after operation
Secondary Outcome Measure Information:
Title
Pain related factors
Description
The scale of the numerical rating score for pain is 0~10 and higher score is worse outcome. Numerical rating score for pain on postoperative day 2 and 3 at 4pm
Time Frame
postoperative day 1,2,and 3
Title
Overall benefit of analgesia score (OBAS)
Description
OBAS on postoperative day 1,2,and 3. This include 7 questions. To calculate the OBAS score, compute the sume of scores in items 1~6 and add "4-socore in item 7". The minimum score is 4 and the maximum is 24.The low score indicates high benefit.
Time Frame
postoperative day 1,2,and 3
Title
Recovery related factors
Description
Time to first eat meal, time to first move, time to first gas out
Time Frame
Within 1 week after operation
Title
Postoperative complication factors
Description
Clavien-Dindo classification, postoperative pancreatic fistula
Time Frame
Within 1 week after operation
Title
analgesic related factors
Description
rescue analgesics amounts, opioid amounts
Time Frame
Within 2 week after operation

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: 18 years and older Disease of periampullary lesions Elective open pancreaticoduodenectomy (PD): PD or pylorus preserving pancreaticoduodenectomy (PPPD) Midline incision Written informed consent : ability to understand and the willingness to sign a written informed consent Performance status (ECOG scale): 0-1 at the time of enrollment Physical status (ASA) : 1-2 grade Exclusion Criteria: History of any abdominal surgery (except laparoscopic appendectomy, laparoscopic/robotic cholecystectomy, laparoscopic/robotic obstetrics and gynecology surgeries,Cesarean section, laparoscopic/robotic prostate surgery) Emergency operation History of chronic pain Chronic use of opioid, analgesics, anti-depressant, anti-epileptics (>1year) Alcoholics Impossible to control PCA d/t delirium, cognitive impairment Contraindication for epidural analgesia Patients with coagulopathy (INR>1.5, Prothrombin time>1.5, platelets <80x10^9perL) or anti-coagulants Hypersensitive to fentanyl and ropivacaine Need other organ resection (ex. Liver, colon) Intubation
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Jin-Young Jang, M.D., PhD.
Phone
82-2-2072-2194
Email
jangjy4@snu.ac.kr
First Name & Middle Initial & Last Name or Official Title & Degree
Yoo Jin Choi, M.D.
Phone
82-2-2072-1959
Email
ujinny30@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jin-Young Jang, M.D., PhD.
Organizational Affiliation
Seoul National University Hospital
Official's Role
Study Chair
Facility Information:
Facility Name
Department of Surgery, Seoul National University College of Medicine
City
Seoul
ZIP/Postal Code
110-744
Country
Korea, Republic of
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jin- Young Jang, M.D., PhD.
Phone
82-2-2072-2194
Email
jangjy4@gmail.com
First Name & Middle Initial & Last Name & Degree
Wooil Kwon, M.D., PhD.
Phone
82-2-2072-2817
Email
willdoc78@gmail.com
First Name & Middle Initial & Last Name & Degree
Jin- Young Jang, M.D., PhD.
First Name & Middle Initial & Last Name & Degree
Wooil Kwon, M.D., PhD.
First Name & Middle Initial & Last Name & Degree
Hongbeom Kim, M.D.

12. IPD Sharing Statement

Learn more about this trial

Preperitoneal Analgesia Versus Epidural Analgesia After Open Pancreaticoduodenectomy

We'll reach out to this number within 24 hrs